about
Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course studyHypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuliIdentification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptorGPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushingSoluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesCastor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptorsCOX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerLoss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expressionSensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins.Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesEffects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exerciseProstaglandin E2 and T cells: friends or foes?Lipid mediators and allergic diseasesThe role of prostaglandins in allergic lung inflammation and asthmaA Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide HydrolaseAn Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and DiseasesOvarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progressionIloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungsEET signaling in cancerA generalizable platform for interrogating target- and signal-specific consequences of electrophilic modifications in redox-dependent cell signalingEpoxides and soluble epoxide hydrolase in cardiovascular physiologyProstaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptorsImpaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty ratsNerve growth factor mediates a switch in intracellular signaling for PGE2-induced sensitization of sensory neurons from protein kinase A to EpacNovel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeImpaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor.Acute effects of prostaglandin E1 and E2 on vascular reactivity and blood flow in situ in the chick chorioallantoic membrane.PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy.Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication.Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.Cyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colonEndothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors.E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infectionThe protection of meloxicam against chronic aluminium overload-induced liver injury in rats.Lead optimization studies of cinnamic amide EP2 antagonistsCyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression.Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling.Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling
P2860
Q21261389-B1463706-5CCC-47A2-A026-98E51E324E71Q24339277-F314C583-238B-4BB6-9A90-326341B35946Q24529849-9031398D-11CF-4255-AE2F-E88EA13B8745Q24536109-908B187C-4A13-45D9-A56A-E73A9F3C780AQ24597172-BE513C3B-C93A-4423-8342-DF693B4540FAQ24597553-F07F7D91-085B-4A1E-B512-6E14827DCF3BQ24651871-13FBB979-068D-4D00-B5A7-33A316772018Q24684962-C9EB068C-5670-4FA2-BD40-91D1FBA09E86Q24806526-DDFDA11C-F57F-4BFE-AA0D-24C64B312B4EQ26771378-C2F25812-A706-48C6-BAC9-5E320F3BC84CQ26862642-1226C8CC-3814-438B-BD20-1DF72E13478DQ26996419-8E5B33D6-3442-411A-B1A6-4663E2A5C107Q27021151-B34217ED-1F99-4005-A309-3306051C0E1EQ27023936-7E255A94-6255-4757-B9D7-262645E9ADD4Q27024735-30CD4630-BBC4-413B-B399-0590A213D123Q27675504-055A7C04-A8C4-4E80-BA01-79500541FBA6Q28067884-AC7FF64E-D251-42B1-9D30-2A98B9920A10Q28210448-6FA505AD-2AA3-4E2D-9617-07B091A6EAF8Q28218337-F74223CC-7EFF-499C-826F-A34E77818DE1Q28250730-AE015A0C-4B7B-446D-80BF-7600E310DC10Q28385286-21B2DA14-F59A-4F15-9226-6005422320BBQ28396313-1805BB28-2C51-47B5-8DA7-0CBCAE11D019Q28569384-177ABA3A-D670-43BB-B299-2B4C555EAC91Q28581479-983E1F97-6338-462B-950B-FABE9B7AC97BQ28581578-61524C84-DB43-44F6-A1A2-AF795A798A07Q28586698-258D96C9-704B-4475-AAB8-93543AED5B7BQ30481647-DFD21F89-A4D5-45EF-B180-A44B51FE7F14Q30557738-0B0C8DBC-E2C9-418A-9A3A-7ABDF123551EQ30994732-97C51ED4-8EF6-49AF-A9AB-C4C5436196D4Q33200367-95580178-D9FB-40E2-B0DD-403E8FAF1732Q33475171-977FA273-C237-4E51-8A31-DC7FDBB001F7Q33557964-289B870D-A4BA-47E7-AD6B-5E045E8A9BCAQ33569548-4D8E9A89-3ADB-498B-8628-95459DA32083Q33569560-FA25780F-03BF-4031-AC21-23C754FFA932Q33594642-10DC6F95-2364-45F6-AD68-CAF6E15F1193Q33618717-379C29A9-1BFA-4614-8014-F3725D42EC62Q33654575-11170ECE-4843-408F-92D5-DD8EBF8475D0Q33674243-5AD9787B-9A9E-49BB-A39B-E570D6F231D3Q33714751-96C05E8E-BC50-4DCF-889B-3D28AE9DF072Q33714809-F7655ED2-9FA5-48DD-81BD-2216B3FFAAD4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Prostanoid receptors: subtypes and signaling.
@ast
Prostanoid receptors: subtypes and signaling.
@en
Prostanoid receptors: subtypes and signaling.
@nl
type
label
Prostanoid receptors: subtypes and signaling.
@ast
Prostanoid receptors: subtypes and signaling.
@en
Prostanoid receptors: subtypes and signaling.
@nl
prefLabel
Prostanoid receptors: subtypes and signaling.
@ast
Prostanoid receptors: subtypes and signaling.
@en
Prostanoid receptors: subtypes and signaling.
@nl
P2093
P1476
Prostanoid receptors: subtypes and signaling.
@en
P2093
Bagdassarian CK
P304
P356
10.1146/ANNUREV.PHARMTOX.41.1.661
P577
2001-01-01T00:00:00Z